An Avalere study suggested 340B duplicate discounts could increase as a result of Medicare drug price negotiations.
Paper Warns on Duplicate Discounts from 340B Ceiling Price, Medicare Maximum Price
Timelines for manufacturers to provide new Medicare “maximum fair prices” (MFPs) and 340B ceiling prices on drugs are misaligned, risking [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.